Nonalcoholic steatohepatitis (NASH) is the progressive form of liver injury that carries a ... related to the specific lesions in the pathology of NASH, including the challenges of pediatric ...

Metabolic dysfunction-associated steatohepatitis (MASH) is a polygenic disorder influenced by multiple genes, but their ...

For the first time, the European Medicines Agency has recognized AI software for the diagnosis of fatty liver hepatitis as ...

EMA’s human medicines committee qualifies first AI tool to diagnose inflammatory liver disease in biopsy samples: Amsterdam, The Netherlands Saturday, March 22, 2025, 16:00 Hrs ...

The result suggests that the protein made by the gene, known as Nwd1, and other molecules it interacts with could be ...

PathAI, a global leader in AI-powered pathology, today announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has granted full qualification for ...

The findings from the new study in The American Journal of Pathology ... progress to a more severe stage including liver inflammation (nonalcoholic steatohepatitis, NASH) and scarring (liver ...

HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the ...

Metabolic dysfunction-associated steatohepatitis (MASH) is a liver disease that progresses without symptoms and is associated with significant global public health concerns.

Metabolic dysfunction-associated steatohepatitis (MASH) is a liver disease that progresses ... A key factor in the pathology of MASH is the disruption of endoplasmic reticulum (ER) homeostasis.